It has been shown that in pediatric B-cell ALL's, for instance, that those with CD34 positivity responded better to chemotherapy than those without CD34 expression. Therefore, there was a higher rate of recurrence in those cases lacking CD34 expression.
This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:51:40 EST